Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1033 Results

View

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-9431

Cytogenetic, Molecular and Cellular Biology Studies in Metastatic Melanoma Patients, Ancillary

Research Committee(s)

Melanoma

Activated

11-15-1996

Closed

12-15-2005

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-9455

A Phase II Study of 5-FU Infusion and Alpha Interferon for Treatment of Advanced or Recurrent Metastatic Adenocarcinoma of the Bladder

Research Committee(s)

Genitourinary Cancer

Activated

11-15-1996

Closed

12-01-1998

Closed

Phase

Accrual

93%

Published

SWOG Clinical Trial Number

S9628

Phase II Study of Dexamethasone/Alpha Interferon In AL Amyloidosis

Research Committee(s)

Myeloma

Activated

11-01-1996

Closed

03-15-2003

Closed

Phase

Accrual

78%

Published

SWOG Clinical Trial Number

SWOG-9510

Evaluation of Topotecan in Hormone Refractory Prostate Cancer, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

11-01-1996

Closed

08-15-1999

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S9617

A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML).

Research Committee(s)

Leukemia

Activated

11-01-1996

Closed

09-01-1998

Closed

Phase

Accrual

SWOG Clinical Trial Number

S9615

Neoadjuvant Hormonal Therapy Prior to Radical Prostatectomy for T1 - 2 Adenocarcinoma of the Prostate, Phase III

Research Committee(s)

Genitourinary Cancer

Activated

10-15-1996

Closed

07-01-1998

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9504

A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer

Research Committee(s)

Lung Cancer

Activated

10-15-1996

Closed

12-01-1998

Closed

Phase

Accrual

96%

Published

SWOG Clinical Trial Number

S9618

Phase II Trial of Carboplatin Followed by Dose Intense Paclitaxel, Followed by Maintenance Paclitaxel Therapy in Stage IV Ovarian, Fallopian Tube and Peritoneal Cancers

Activated

10-01-1996

Closed

09-15-1999

Closed

Phase

Accrual

86%

Published

SWOG Clinical Trial Number

SWOG-9457

Paclitaxel (Taxol®) and Carboplatin for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

07-15-1996

Closed

04-15-2000

Closed

Phase

Accrual

55%

Published

SWOG Clinical Trial Number

S9623

A Comparison of Intensive Sequential Chemotherapy using Doxorubicin plus Paclitaxel plus Cyclophosphamide with High Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Support for Primary Breast Cancer in Women with >= 4 Involved Axillary Lymph Nodes, Phase III, Intergroup.

Research Committee(s)

Breast Cancer

Activated

07-01-1996

Closed

02-15-2001

Closed

Phase

Accrual

68%

Published

SWOG Clinical Trial Number

SWOG-9519

Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Research Committee(s)

Head and Neck Cancer

Activated

06-15-1996

Closed

11-01-1997

Closed

Phase

Accrual

34%

Published

SWOG Clinical Trial Number

SWOG-9460

Phase IIb Randomized Chemoprevention Trial of N-(4-Hydroxyphenyl) Retinamide (4-HPR) in Transitional Cell Bladder Carcinoma

Activated

06-01-1996

Closed

10-15-1999

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S9619

Phase II Trial of Intraperitoneal Cisplatin and Intravenous and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian Cancer, Intergroup

Activated

05-15-1996

Closed

05-15-1998

Closed

Phase

Accrual

87%

Published

SWOG Clinical Trial Number

SWOG-9451

Induction Chemotherapy Followed by Chemoradiation for Organ Preservation in Patients with Advanced Resectable Cancer of the Hypopharynx and Base of Tongue, Phase II

Research Committee(s)

Head and Neck Cancer

Activated

04-12-1996

Closed

12-01-2001

Closed

Phase

Accrual

55%

Published

SWOG Clinical Trial Number

SWOG-9518

Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas

Research Committee(s)

Sarcoma

Activated

04-01-1996

Closed

10-15-1997

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9509

A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Vinorelbine and Cisplatin in Untreated Advanced Non-Small Cell Lung Cancer

Research Committee(s)

Lung Cancer

Activated

04-01-1996

Closed

01-01-1998

Closed

Phase

SWOG Clinical Trial Number

SWOG-9448

An Investigation of Association Between DNA Adduct Formation With Treatment Response and a Limited Sampling Study of Carboplatin Pharmacokinetics in Previously Untreated Ovarian Cancer Patients Registered to SWOG-9249

Activated

03-15-1996

Closed

07-01-1998

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-9521

Evaluation of Nuclear p53 in Patients with Epithelial Ovarian Cancer Patients Registered to SWOG-8835, Ancillary

Research Committee(s)

Gynecologic Cancer

Activated

03-01-1996

Closed

11-01-1998

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9407

Evaluation of Oral Estramustine and Oral Etoposide in Patients with Hormone Refractory Adenocarcinoma of the Prostate, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

03-01-1996

Closed

07-01-1996

Closed

Phase

Accrual

15%

SWOG Clinical Trial Number

SWOG-9327

Randomized Phase II Pilot Study of Pentoxifylline (Trental®) and Placebo in Patients with Metastatic Malignancy and Anorexia/Cachexia Syndrome

Activated

02-15-1996

Closed

12-15-1997